At a glance
| Abbreviation | CHIKV |
|---|---|
| ICTV species | Alphavirus chikungunya |
| Family | Togaviridae |
| Baltimore class | IV — (+)ssRNA |
| Human infection | Human infection recorded; pattern not classified |
Also called: Alphavirus chikungunya
Riboviria › Kitrinoviricota › Alsuviricetes › Martellivirales › Togaviridae › Alphavirus
What it is
Taxonomy copied from ICTV MSL41.v1 / VMR_MSL41.v1.20260729.xlsx. These ranks are not hand-edited; a correction means re-running the fetch against a newer release.
| Realm | Riboviria |
|---|---|
| Kingdom | Orthornavirae |
| Phylum | Kitrinoviricota |
| Class | Alsuviricetes |
| Order | Martellivirales |
| Family | Togaviridae |
| Genus | Alphavirus |
| ICTV identifier | ICTV19710074 |
| NCBI taxon | 3426298 |
| Exemplar isolate | AF369024 |
Host evidence
- human: 10,216 GenBank records
Counts of nucleotide records annotated with that host. Evidence of provenance, not a statement of host range.
Where it occurs
Not searched yet. No country-level occurrence data has been curated for this virus. The WHO reported-case data on this site covers a limited set of diseases; a virus outside it gets no map rather than an empty one.
What it does
Not searched yet. Burden, severity and transmissibility figures have not been curated for this virus yet. When they are, each will carry the exact sentence from its source.
Vaccines
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| Chikungunya Vaccine, Recombinant | See FDA listing | Not searched yet | Routine immunisation | Approved | US: approved | — | candidateId fda-chikungunya-vaccine-recombinant (targetDisease 'Chikun |
| Ixchiq (VLA1553 / Chikungunya live-attenuated vaccine) | Valneva | live attenuated | Routine immunisation | Approved | US: approved EU: approved Canada: approved Australia: under review (company estimate) | — | candidateId ixchiq (targetDisease 'Chikungunya'); stage copied, not re |
| VIMKUNYA | Bavarian Nordic A/S Bavarian Nordic, Inc. 1005 Slater Road, Suite 101 Durham, NC 27703 Lic. # 2096 | Not searched yet | Routine immunisation | Approved | US: approved | — | candidateId fda-vimkunya (targetDisease 'Chikungunya'); stage copied, |
| IXCHIQ | Valneva Austria GmbH | Not searched yet | Routine immunisation | Approved (restricted) | Not searched yet | — | candidateId fda-ixchiq (targetDisease 'Chikungunya'); stage copied, no |
In development
| Name | Developer | Platform | Use | Stage | Jurisdictions | Trials | Source |
|---|---|---|---|---|---|---|---|
| CHIKV VLP vaccine (PXVX0317, Vimkunya) | Bavarian Nordic | virus like particle | Routine immunisation | Phase 3 | Not searched yet | NCT06007183 | candidateId ctgov-chikv-vlp-vaccine-booster-bavarian-nordic (targetDis |
| VLA1553 | Valneva Austria GmbH | Not searched yet | Routine immunisation | Phase 3 | Not searched yet | NCT06028841 NCT07133178 NCT04838444 | candidateId ctgov-vla1553-valneva-austria-gmbh (targetDisease 'Chikung |
Antivirals
Not searched yet. No US-approved antiviral for this virus was found in the openFDA drug label endpoint. Only US labels were searched, and only drugs the FDA classes as antivirals.
Antibodies and immune globulins
Not searched yet. No US-approved antiviral antibody for this virus was found in the openFDA drug label endpoint.
Approval status is not a treatment recommendation. Dosing and eligibility are on the label and in national guidelines. This page does not give medical advice and does not render dosing. A development stage is not a measure of how well something works.
Related on this site
- Vaccine pipeline — candidates listed under “Chikungunya”
- Other Togaviridae viruses